169447-93-2 Usage
Molecular structure
1-Piperazinecarboxylic acid, 2-(2-methoxyethyl)-4-(phenylmethyl)-, 1,1-dimethylethyl ester, (2S)is a complex organic compound that features a piperazine ring, a methoxyethyl group, a phenylmethyl group, and a 1,1-dimethylethyl ester moiety.
Stereochemistry
This compound is a 2S stereoisomer, which means it has a specific three-dimensional arrangement of its atoms.
Classification
It belongs to the piperazine class of compounds, which are a group of organic compounds that contain a piperazine ring.
Uses
This compound is commonly used as a reagent in organic synthesis and pharmaceutical research, and as a building block in the synthesis of various pharmaceuticals and agrochemicals.
Piperazine ring
A heterocyclic ring structure that consists of five members, with two of the atoms being nitrogen.
Methoxyethyl group
A group that consists of an ethyl group (two carbon atoms connected by a single bond) with a methoxy group (an oxygen atom connected to a methyl group) attached to it.
Phenylmethyl group
A group that consists of a phenyl group (a six-carbon ring with delocalized electrons) connected to a methyl group (a single carbon atom connected to three hydrogen atoms).
1,1-Dimethylethyl ester moiety
A functional group that consists of an ester group (a carbonyl group connected to an oxygen atom) with two methyl groups attached to the carbon atom that is connected to the oxygen atom.
Medicinal chemistry and drug discovery
This compound has potential applications in medicinal chemistry and drug discovery due to its unique structure and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 169447-93-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,9,4,4 and 7 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 169447-93:
(8*1)+(7*6)+(6*9)+(5*4)+(4*4)+(3*7)+(2*9)+(1*3)=182
182 % 10 = 2
So 169447-93-2 is a valid CAS Registry Number.
169447-93-2Relevant articles and documents
17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
-
Page 19-20, (2008/06/13)
In its many embodiments, the present invention provides a novel class of compounds as inhibitors of type 3 17β-hydroxysteroid dehydrogenase, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of
Thioproline-containing inhibitors of farnesyl protein transferase
-
, (2008/06/13)
Inhibition of farnesyl transferase, which is an enzyme involved in ras oncogene expression, is effected b STR1 its enantiomers, diastereomers, and pharmaceutically acceptable salts and solvates thereof.
